SHORT MINI FUTURE WARRANT - MERCK & CO. | Market Closed - BOERSE MUENCHEN 02:26:55 2024-07-12 pm EDT | ||
| 2.12 EUR | +0.95% |
|
| Current month | +1.92% | ||
| 1 month | +8.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 2.12 | +0.95% |
| 24-07-11 | 2.1 | -5.41% |
| 24-07-10 | 2.22 | -6.33% |
| 24-07-09 | 2.37 | +1.72% |
| 24-07-08 | 2.33 | -0.43% |
Real-time BOERSE MUENCHEN
Last update July 12, 2024 at 02:26 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG30FK |
| ISIN | DE000GG30FK4 |
| Date issued | 2024-02-09 |
| Strike | 151 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.869 € |
|---|---|
| Lowest since issue | 1.58 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.8
USD
Average target price
142.6
USD
Spread / Average Target
+11.59%
- Stock Market
- Certificates
- Certificat
